| Literature DB >> 25875476 |
Andreas Frings1, Gisbert Richard1, Johannes Steinberg1, Christos Skevas1, Vasyl Druchkiv1, Toam Katz1, Stephan J Linke1.
Abstract
PURPOSE: In eyes with a preoperative plano refractive cylinder, it would appear that there is no rationale for astigmatic treatment. The aim of this retrospective, cross-sectional data analysis was to determine the amount of topographic astigmatism in refractive plano eyes that results in reduced efficacy after myopic laser in situ keratomileusis (LASIK).Entities:
Mesh:
Year: 2015 PMID: 25875476 PMCID: PMC4398356 DOI: 10.1371/journal.pone.0124313
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Descriptives.
| Preoperative ORA(1) | Low (<0.9) ORA (n = 153) | High (≥0.9) ORA (n = 114) | Total (N = 267) | P(2) | |||
|---|---|---|---|---|---|---|---|
| Min/Max | Mean (SD) | Min/Max | Mean (SD) | Min/Max | Mean (SD) | ||
| age (y) | 19/68 | 33(±10) | 19/63 | 35(±10) | 19/68 | 34(±10) | 0.236 |
| Scotopic pupil size (mm) | 4.0/8.0 | 6.5(±0.7) | 4.5/9.0 | 6.5(±0.7) | 4.0/9.0 | 6.5(±0.7) | 0.513 |
|
| |||||||
| CDVA(3) (LogMar) | -0.12/0.15 | -0.03(±0.05) | -0.14/0.34 | -0.02(±0.06) | -0.14/0.34 | -0.02(±0.05) | 0.077 |
| UDVA(4) (LogMAr) | 0.00/2.00 | 1.18(±0.67) | 0.00/2.00 | 1.18(±0.62) | 0.00/2.00 | 1.18(±0.65) | 0.995 |
| sphere (D) | -8.00/-0.75 | -3.58(±1.49) | -8.00/-1.00 | -3.74(±1.77) | -8.00/-0.75 | -3.65(±1.62) | 0.413 |
| topographic cyl (D) (= ORA magnitude (D)) | -0.80/-0.10 | -0.50(±0.21) | -2.00/-0.90 | -1.11(±0.22) | -2.00/-0.10 | -0.76(±0.37) | 0.000 |
| ORA axis (°) | 5/174 | 88(±31) | 21/178 | 89(±14) | 5/178 | 89(±25) | 0.796 |
|
| |||||||
| CDVA (LogMar) | -0.20/0.10 | -0.04(±0.05) | -0.18/0.19 | -0.02(±0.07) | -0.20/0.19 | -0.03(±0.06) | 0.010 |
| UDVA (LogMAr) | -0.20/0.44 | -0.01(±0.08) | -0.16/2.00 | 0.05(±0.22) | -0.20/2.00 | 0.01(±0.16) | 0.001 |
| sphere (D) | -0.75/2.50 | 0.24(±0.46) | -1.75/2.50 | 0.22(±0.56) | -1.75/2.50 | 0.23(±0.51) | 0.793 |
| subjective cyl (D) | -1.25/-0.25 | -0.40(±0.19) | -2.00/-0.25 | -0.47(±0.33) | -2.00/-0.25 | -0.43(±0.26) | 0.030 |
| topographic cyl (D) | -1.90/0.00 | -0.65(±0.37) | -2.10/-0.20 | -1.13(±0.38) | -2.10/0.00 | -0.86(±0.44) | 0.000 |
| Spherical Equivalent (D) | -1.00/2.13 | 0.04(±0.43) | -2.00/2.13 | -0.01(±0.56) | -2.00/2.13 | 0.02(±0.49) | 0.400 |
| ORA magnitude (D) | 0.05/1.54 | 0.55(±0.31) | 0.05/2.46 | 0.95(±0.42) | 0.05/2.46 | 0.72(±0.41) | 0.000 |
| ORA axis (°) | 3/175 | 91(±34) | 9/152 | 93(±20) | 3/175 | 92(±29) | 0.606 |
| Refractive SIA(5) magnitude (D) | 0.25/1.25 | 0.40(±0.19) | 0.25/2.00 | 0.47(±0.33) | 0.25/2.00 | 0.43(±0.26) | 0.030 |
| Refractive SIA (°) | 4/180 | 83(±46) | 5/180 | 81(±36) | 4/180 | 83(±42) | 0.721 |
| Refractive TSIA(6) magnitude (D) | 0.03/1.73 | 0.43(±0.30) | 0.00/3.09 | 0.50(±0.45) | 0.00/3.09 | 0.46(±0.37) | 0.111 |
| Refractive TSIA (°) | 1/180 | 86(±47) | 0/177 | 93(±55) | 0/180 | 89(±51) | 0.273 |
| Efficacy Index | 0.36/1.33 | 0.98(±0.15) | 0.01/1.25 | 0.91(±0.21) | 0.01/1.33 | 0.95(±0.18) | 0.002 |
| Safety Index | 0.70/1.39 | 1.04(±0.12) | 0.64/1.39 | 1.02(±0.12) | 0.64/1.39 | 1.03(±0.12) | 0.255 |
1 = Ocular residual astigmatism; 2 = P value <0.05 was considered as significant; 3 = corrected distance visual acuity; 4 = uncorrected distance visual acuity; 5 = refractive surgically induced astigmatism (subjectively manifest SIA); 6 = topographic SIA; Means of astigmatism were calculated by arithmetic means.
ROC (receiver operating characteristic) analysis.
| Cut-off | ORA(1) cut-off | AUC(2) | SE(3) | Sensitivity | Specificity | P(4) |
|---|---|---|---|---|---|---|
|
| ||||||
| 0.7 | 0.900 | 0.354 | 0.061 | 0.397 | 0.280 | 0.016 |
| 0.8 | 0.900 | 0.376 | 0.049 | 0.382 | 0.362 | 0.013 |
| 0.9 | 0.800 | 0.407 | 0.039 | 0.473 | 0.434 | 0.017 |
| 1.0 | 0.800 | 0.456 | 0.039 | 0.480 | 0.490 | 0.260 |
|
| ||||||
| 0.9 | 0.8 | 0.511 | 0.068 | 0.508 | 0.552 | 0.872 |
| 1 | 0.8 | 0.463 | 0.036 | 0.496 | 0.493 | 0.304 |
| 1.1 | 0.8 | 0.509 | 0.045 | 0.537 | 0.507 | 0.847 |
| 1.2 | 0.8 | 0.493 | 0.061 | 0.583 | 0.506 | 0.915 |
1 = ocular residual astigmatism; 2 = Area under the curve; 3 = Spherical Equivalent; 4 = P value <0.05 was considered as significant; 5 = Efficacy Index; 6 = Safety Index.
Ordinary least square regression (OLS) analysis.
| True class | ||||
|---|---|---|---|---|
| Low (EI(1) 0.01–0.8) | High (EI 0.82–1.33) | Total | ||
|
|
| 17 | 136 | 153 |
|
| 30 | 84 | 114 | |
|
| 47 | 220 | 267 | |
|
| 0.38 | |||
|
| 0.64 | |||
|
| 0.38 | |||
|
| 0.36 | |||
|
| 0.38 | |||
1 = Efficacy Index; 2 = ocular residual astigmatism
Bivariate ordinary least square regression (OLS) analysis.
| Coefficient | Std. Err. | t(2) | P(3) | 95% Conf. Interval | ||
|---|---|---|---|---|---|---|
|
| ||||||
|
| -0.07 | 0.03 | -2.37 | 0.02 | -0.13 | -0.01 |
|
| 1.00 | 0.03 | 39.73 | 0.00 | 0.95 | 1.05 |
|
| ||||||
|
| -0.02 | 0.02 | -0.80 | 0.43 | -0.05 | 0.02 |
|
| 1.04 | 0.02 | 62.22 | 0.00 | 1.01 | 1.07 |
1 = Efficacy Index; 2 = empirical t value (coefficient/SE); 3 = significance; 4 = ocular residual astigmatism; 5 = Safety Index